Re: BETonMACE Enrollment

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Top-Line Data Expected September 2019 for BETonMACE Phase 3 Cardiovascular Outcomes Trial for Apabetalone

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Carpe Diem

Rank: Mail Room [?]

Points: 165 [?]

Votes: 10 Score: 1.9 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: BETonMACE Enrollment

in response to

Re: BETonMACE Enrollment

BearDownAZ

posted on Feb 11, 2019 09:05AM

Bear,

Thanks for the reading assignement. I do recall now that BETonMACE did exclude patients with ALT/AST levels greater than 1.5 the upper limits.

Interesting to see where the liver research takes us. This opens up a whole new market.

1 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply